The forkhead transcription factor, Foxd3, plays a critical role during development by controlling the lineage specification of neural crest cells. Notably, Foxd3 is highly expressed during the wave of neural crest cell migration that forms peripheral neurons and glial cells but is down-regulated prior to migration of cells that give rise to the melanocytic lineage. Melanoma is the deadliest form of skin cancer and is derived from melanocytes. Recently, we showed that FOXD3 expression is elevated following the targeted inhibition of the B-RAF-MEK-ERK1/2 pathway in mutant B-RAF melanoma cells. Since melanoma cells are highly migratory and invasive in a B-RAF-dependent manner, we explored the role of FOXD3 in these processes. In this study, we show that ectopic FOXD3 expression inhibits the migration, invasion and spheroid outgrowth of mutant B-RAF melanoma cells. Up-regulation of FOXD3 expression following inhibition of B-RAF and MEK correlates with the down-regulation of Rnd3, a Rho GTPase and inhibitor of RhoA-ROCK signaling. Indeed, expression of FOXD3 alone was sufficient to down-regulate Rnd3 expression at the mRNA and protein levels. Mechanistically, FOXD3 was found to be recruited to the Rnd3 promoter. Inhibition of ROCK partially restored migration in FOXD3-expressing cells. These data show that FOXD3 expression down-regulates migration and invasion in melanoma cells and Rnd3, a target known to be involved in these properties.
Introduction
Transformation of melanocytes gives rise to melanoma which is the deadliest form of skin cancer. In contrast to other cancers for which the overall incidence has decreased in recent years, melanoma has shown an alarming increase in the number of new cases. Melanocytes reside in the epidermis, the outermost layer of the skin. During transformation, cells accumulate in the epidermis and papillary dermal layer as radial growth phase tumors. Following the acquisition of invasive properties, vertical growth phase melanoma cells invade en masse down into the underlying dermis. The depth of invasion is used as a clinical correlate for a poor prognosis (1) . Thus, it is critically important to understand the mechanisms that regulate the migratory and invasive properties of melanoma.
Activating mutations in the serine-threonine kinase B-RAF occur in approximately 60% of melanoma cases (2) . The most frequent mutation, B-RAF V600E , results in elevated kinase activity that is independent of upstream RAS signaling (2) . In this manner, B-RAF V600E stimulates extracellular signal-regulated kinase (ERK) signaling leading to increased cell proliferation and survival (3, 4) . Additionally, depletion of B-RAF by RNA interference inhibits melanoma cell invasion through Matrigel (5) . The molecular mechanisms underlying these growth and invasive phenotypes are yet to be clearly determined; however, they are likely to be complex since B-RAF mutations have also been detected in non-malignant nevi. Notably, the levels of phospho-ERK1/2 are low in nevi, likely due to feedback inhibition (6) .
Cell migration and invasion are regulated by the family of Rho proteins including RhoA, Rac1, and Cdc42 that work as molecular switches to ultimately regulate actin cytoskeletal structures (7) . Rnd3, also known as RhoE/Rho8, is an additional member of the Rho family (8) .
Unlike other Rho family members, Rnd3 lacks GTPase activity resulting in its constitutive GTP binding. Notably, Rnd3 binds p190RhoGAP to antagonize RhoA functions and inhibit actin stress fiber formation (9) . Rnd3 is highly expressed in invasive melanoma cells (10) . Recently, we have shown Rnd3 is positively regulated by B-RAF V600E -MEK signaling (11) . Furthermore, we demonstrated that Rnd3 regulates the actin cytoskeleton and is required for melanoma cell migration and invasion in 3D collagen (12) .
Foxd3 is a member of forkhead box (Fox) transcription factor family that is characterized by the presence of a forkhead domain (13) . It binds to DNA with the consensus sequence 5'-A
[AT]T[AG]TTTGTTT-3' (14). Role of Foxd3 in development is well established as it has
shown to be expressed in embryonic stem (ES) cells in the late stage gastrula inner cell mass (epiblast) (15) and is required for extra embryonic tissue (16). Importantly, Foxd3 is essential during normal murine development by maintaining pluripotent cells in the early mouse embryo and is required to establish murine ES cell lines in vitro (15, 17, 18) . A role for Foxd3 later in development has also been established, specifically in premigrating and migrating neural crest cells in avian embryo (19, 20) . Foxd3 is an early molecular marker of neural crest cells and is responsible for the repression of melanogenesis in early migratory neural crest cells (19) .
Interestingly, over-expression of Foxd3 in late migrating neural crest cells that are destined for melanoblast formation results in a shift towards glial and neural cell lineages (19, 21, 22) .
Recently, our lab showed that FOXD3 is up-regulated by inhibition of the B-RAF-MEK pathway in mutant B-RAF melanoma cells and that ectopic expression of Foxd3 in melanoma cells induces a G1-S phase arrest (23) . Since Foxd3 has been implicated in the migration and invasion in neural crest cells, we tested its role in the regulation of migration and invasion in mutant B-RAF melanoma cells.
Materials and Methods

Cell culture
Human mutant B-RAF WM793 and wild-type B-RAF WM3211 melanoma cell lines were kindly donated by Dr. Meenard Herlyn (Wistar Institute, Philadelphia, PA) and were cultured in MCDB 153 medium containing 20% Leibovitz L-15 medium, 2% fetal bovine serum (FBS), 0.2% sodium bicarbonate, and 5 μg/mL insulin. A375 cells were purchased from ATCC (Manassas, VA) and were cultured in DMEM with 10% FBS. The generation of WM793TR and A375TR cell lines that inducibly express β-galactosidase (LacZ), mFoxd3, and hFOXD3, has been previously described (23) . Transgene expression was induced by addition of 100 ng/ml doxycycline to the medium.
Antibodies and inhibitors
Primary antibodies used were: ERK1/2 (K-23, Santa Cruz Biotechnology, Inc, Santa (Berkeley, CA). AZD6244 was purchased from Selleck (Houston, TX). U0126 was obtained from Cell Signaling Technology. Y27632 was purchased from Calbiochem (Gibbstown, NJ).
Western blotting
Cells were lysed and lysates analyzed by Western blotting, as previously described (24) .
Chemiluminescence was detected on a Versadoc Multi-Imager and quantitated using Quantity One software (Bio-Rad, Hercules, CA).
Migration and invasion assays
Migration and invasion were assayed by seeding 2.5-3 x 10 4 cells on top of Boyden chamber insert or Matrigel-coated cell culture inserts (BD Biosciences, San Jose, CA), respectively. Serum-free medium was added to the upper chamber, and serum-containing medium to the lower chamber. Cells were allowed to migrate at 37 o C for 6 hrs before fixation.
Membranes were stained and cells were counted from 5 different fields. The average number of migrating cells was taken from three independent experiments.
Spheroid outgrowth assay
Three independent spheroid assays were performed, as previously described (25) . Briefly, 5 x 10 4 cells were seeded in suspension in full serum medium on top of a 2% bactoagar layer and spheroids were allowed to form for 72 hrs at 37°C. Collected spheroids were embedded in 3D collagen and incubated at 37°C for 2 hrs to solidify and medium added on top of the collagen.
Pictures of spheroids were taken 24 hrs after collagen embedding using Nikon Eclipse Tsi inverted microscope with 10X magnification. Next, 100 ng/ml doxycycline was added for a further 48 hrs. At least 10 spheroids were analyzed for each condition. At the end of 48 hrs, live/dead staining of spheroids was performed using the viability/toxicity kit (Invitrogen) as per manufacturer's instructions.
Quantitative Reverse-transcription-PCR (qRT-PCR)
Total RNA was extracted by using PerfectPure RNA cultured cell kit (5 Prime, Gaithersburg, MD). cDNA was prepared by using iScript cDNA synthesis kit (Bio-Rad).
Quantitative PCR was performed using iQ SYBR Green supermix (Bio-Rad) using 400 nM primers, and 0.1 μg cDNA. The primers used to detect Rnd3 were: (forward) 5'-CGTTAAGCGGAACAAATCACAG-3' and (reverse) 5'-CGTAAGTCCGTAGCAACTGC-3'.
For actin, the primers were: (forward) 5'-AGTGTGGTCCTGCGACTTCTAAG-3', and (reverse) 5'-CCTGGGCTTGAGAGGTAGAGTGT-3'. Reaction conditions were denaturation at 94°C for 30 sec, annealing at 50°C for 30 sec, and elongation at 72°C for 30 sec (50 cycles in total). PCR was performed on an iCycler with MyiQ version 1.0 software (Bio-Rad). Relative mRNA levels were calculated using the comparative C t method (26) .
Chromatin Immunoprecipitation (ChIP)
A375TR/mFoxd3 cells were treated with 100 ng/ml doxycycline for 48 hrs. Crosslinking of the DNA-protein complexes was carried out by addition of 37% formaldehyde and After sonication, the lysates were centrifuged, and the supernatant was diluted 10-fold with ChIP dilution buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, pH 8.1, 167 mM NaCl), and 1% of the diluted lysate was used as input for DNA quantitation. 
Results
FOXD3 regulation of migration and invasion
Due to the role of Foxd3 during development, we investigated its role in the migration and invasion of melanoma cells. We focused on mutant B-RAF harboring melanoma cells since of the spheroid were determined. We quantitated spheroid outgrowth by subtracting the core area from the outgrowth of each spheroid. This analysis showed that FOXD3 expression resulted in a statistically significant decrease in spheroid outgrowth (Fig. 2 B) .
Mutant B-RAF inhibition by PLX4720 results in up-regulation of Foxd3
We have previously shown that FOXD3 is up-regulated upon B-RAF knockdown (23) .
Here, we used PLX4720, which selectively inhibits B-RAF-MEK-ERK1/2 signaling in mutant
-expressing melanoma cells (27) . As expected, treatment of mutant B-RAF cell lines with PLX4720 inhibited phospho-ERK1/2 levels in WM793 and A375 cells (Fig. 3A) .
Concomitant with phospho-ERK1/2 inhibition was an increase in FOXD3 expression and a decrease in the expression of the Rho family member, Rnd3 (Fig. 3A) . Additionally, treatment of mutant B-RAF cell lines (WM793 and A375) with the MEK inhibitor, AZD6244, also resulted in an increase in FOXD3 levels and a decrease in Rnd3 expression (Fig. 3B) . Inhibition of MEK in wild-type B-RAF WM3211 cells does not lead to up-regulation of FOXD3 (23) .
Parallel to the lack of effect on FOXD3, Rnd3 was not down-regulated by MEK inhibition in WM3211 cells (Fig. 3C ). These data show that FOXD3 and Rnd3 are regulated in an opposing manner by the B-RAF signaling pathway in mutant B-RAF melanoma cells.
Foxd3 expression down-regulates Rnd3
To determine if Foxd3 can directly regulate Rnd3, we induced expression of mouse RNA level, total RNA was isolated from WM793TR/LacZ and WM793TR/mFoxd3 cells treated with doxycycline for 48 hrs and subjected to qRT-PCR analysis. Consistent with protein data, Rnd3 RNA was also found to be significantly decreased after Foxd3 expression (Fig. 4D) .
Together, these data show that Foxd3 downregulates the expression of Rnd3.
Recruitment of Foxd3 to Rnd3 promoter
Next, we analyzed the human Rnd3 promoter and identified a consensus forkhead transcription factor binding site (-1196 to -1073). ChIP assays were performed with primers flanking this forkhead consensus sequence to test if FOXD3 directly binds to the Rnd3 promoter.
A schematic representation indicating the location of PCR primers flanking the FOXD3 consensus sequence in the Rnd3 promoter is shown in Fig. 5A . A375TR/mFoxd3-V5 cells were used for these experiments since we obtained consistent shearing of 500-1000 bp in this cell type. The presence of an amplified band in ChIPs from A375TR/mFoxd3-V5 cells treated with doxycycline and the absence of this band from the minus doxycycline condition ChIPs, indicated recruitment of Foxd3 to Rnd3 promoter (Fig 5B) . Additionally, recruitment of phosphorylated RNA polymerase II and methylated histone H3K4 to the Rnd3 promoter was abrogated in cells expressing Foxd3. The absence of an amplified band in the no antibody control using normal
IgG antibody indicated the specificity of ChIP (Fig 5B) . Together, these data demonstrate that FOXD3 can be recruited to the human promoter of Rnd3.
Inhibition of ROCK reverses FOXD3 inhibition of migration
Since FosL1/Fra1, which contribute to cell polarization, motility, and invasiveness (32-34).
In our study, we also explored the possible molecular mechanism involved in the Foxd3-mediated inhibition of migration/invasion in melanoma cells. Up-regulation of FOXD3
following inhibition of B-RAF or MEK correlated with a decrease in Rnd3 expression. Rnd3 is a constitutively active, GTP-loaded Rho family member (35) that disrupts actin stress fibers and increases cellular migration (29, 36) . Consistent with these findings in fibroblasts, we reported that Rnd3 knockdown in mutant B-RAF melanoma cells enhanced actin stress fiber formation and inhibited migration and invasion (12) . Our data demonstrates that ectopic Foxd3 expression suppressed Rnd3 levels at both the protein and mRNA levels. In addition, Foxd3 can directly bind to the Rnd3 proximal promoter and, in doing so, it inhibits proper assembly of transcription machinery by interfering with the recruitment of factors such as phosphorylated RNA polymerase II and methylated H3K4. FOXD3 has been proposed to act as both an activator (18) and a repressor (37, 38) of transcription. Our data point to the latter role in terms of regulating Rnd3 expression in melanoma. Recent evidence highlights a number of possible mechanisms whereby FOXD3 can regulate target expression. FOXD3 expression is associated with maintenance of unmethylated marks in gene enhancers (39) and promoter CpG regions (40) .
Additional studies suggest interactions between Foxd3 and other embryonic stem cell factors.
For example, Sox2 has been shown to establish active H3K4 di-and tri-methylation marks in the enhancer of the pre-B cell-specific λ5-VpreB1 locus but Foxd3 blocked intergenic transcription from this locus (38) .
While FOXD3 regulates Rnd3 expression, evidence indicates that additional targets are involved in FOXD3 regulation of migration and invasion. Of note, the effect of FOXD3 expression on the actin cytoskeleton differs from Rnd3 depletion. FOXD3 expression led to a spindle cell morphology with disrupted F-actin stress fibers (data not shown); whereas Rnd3 depletion enhances actin stress fiber formation (12) . Thus, we believe that Rnd3 is required for migration and outgrowth of melanoma cells, based on Rnd3 knockdown experiments (12), but is not the only regulator. In summary, through this study we revealed that B-RAF inhibition results in up-regulation of FOXD3 and it is likely that FOXD3 regulates Rnd3 and other targets that inhibit to the migration and invasion phenotypes in melanoma cells (Fig. 7) . A, Inducible WM793TR/mFoxd3 cells were treated with 100 ng/ml doxycycline (Dox) for the indicated time points. Cell lysates were analyzed for Foxd3 expression by Western blot. Actin serves as a loading control. B, As for A, except A375TR/mFoxd3 cells were used. C, WM793TR/mFoxd3 cells were allowed to migrate through uncoated Boyden chambers for 6 hrs.
Representative pictures for the underside of the filters are shown. Quantitation of cells which have migrated through the Boyden chamber is the mean and standard deviation from three independent experiments. D, As for C, except that A375TR/mFoxd3 cells were used. E, WM793TR/mFoxd3 cells were allowed to invade overnight through Matrigel-coated chambers.
F, As for E, except that A375TR/mFoxd3 cells were used. *p<0.005 
